» Articles » PMID: 18095319

Characteristics and Survival of 750 Children Diagnosed with a Renal Tumor in the First Seven Months of Life: A Collaborative Study by the SIOP/GPOH/SFOP, NWTSG, and UKCCSG Wilms Tumor Study Groups

Overview
Date 2007 Dec 21
PMID 18095319
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To review the clinical characteristics and survival of infants diagnosed with a primary renal tumor in the first 7 months of life.

Procedure: A retrospective data review of patients registered in five large international protocols (SFOP/GPOH/SIOP9/93-01, UKW3 and NWTSG 4 and 5) spanning 1985-2002.

Results: 750 (7.2%) of 10,430 registered patients were diagnosed with a renal tumor before age 213 days. Tumor types were Wilms tumor (WT) 58%; congenital mesoblastic nephroma (CMN) 18%; malignant rhabdoid tumor (MRTK) 8%; clear cell sarcoma (CCSK) 2%; non-Wilms tumor (unspecified) 6%; histology unknown, 9%. CMN predominated among tumors diagnosed in the first month of life (54%) but its relative contribution diminished to <10% of all cases diagnosed after the age of 3 months (P < 0.001). Among 639 cases with specified histology and stage, 9/11 stage IV tumors were MRTK, 37/39 bilateral tumors were WT. In 626 children where surgical approach was specified, 522 had immediate nephrectomy. For all cases, 5 years event-free survival (EFS) was 80% and overall survival (OS) 86%. Five years EFS and OS respectively by tumor type were WT (86%, 93%), CMN (94%, 96%), CCSK (49%, 51%), MRTK (16%, 16%).

Conclusion: Renal tumors diagnosed in the first 7 months of life generally have an excellent prognosis though histology is an important prognostic factor. In the first 2 months of life the prevalence of CMN is high. The relative occurrence of WT increases rapidly with age thereafter. Bilateral tumors are usually WT. Tumors with metastases at diagnosis are usually MRTK.

Citing Articles

Current surgical approaches to pediatric renal tumors.

Glick R, Romao R, Pachl M, Kotagal M, Buchanan A, Murphy A Pediatr Blood Cancer. 2024; :e31118.

PMID: 38809413 PMC: 11604818. DOI: 10.1002/pbc.31118.


Contrast-enhanced ultrasound for differentiating benign from malignant focal solid renal lesions in pediatric patients.

Fu Y, Zhong J, Tan Y, Zheng T, Liu M, Wang G Sci Rep. 2024; 14(1):11409.

PMID: 38762673 PMC: 11102535. DOI: 10.1038/s41598-024-62496-z.


Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel study.

van der Beek J, Schenk J, Morosi C, Watson T, Coma A, Graf N Pediatr Radiol. 2024; 54(6):965-976.

PMID: 38609702 PMC: 11111520. DOI: 10.1007/s00247-024-05918-4.


Fetal Wilm's tumor detection preceding the development of isolated lateralized overgrowth of the limb: a case report and review of literature.

Bechara E, Saade C, Geagea C, Charouf D, Abou Jaoude P Front Pediatr. 2024; 12:1334544.

PMID: 38562132 PMC: 10982349. DOI: 10.3389/fped.2024.1334544.


Hallmark discoveries in the biology of Wilms tumour.

Perotti D, Williams R, Wegert J, Brzezinski J, Maschietto M, Ciceri S Nat Rev Urol. 2023; 21(3):158-180.

PMID: 37848532 DOI: 10.1038/s41585-023-00824-0.